Christopher Hall
About Christopher Hall
Christopher Hall is a Therapeutic Policy and Research Pharmacy Intern at UF Health Jacksonville, where he has worked since 2021. He has extensive experience in pharmacy, having previously held roles at UF Health and Winn-Dixie, and has a Doctor of Pharmacy degree from the University of Florida.
Work at UF Health Jacksonville
Christopher Hall currently serves as a Therapeutic Policy and Research Pharmacy Intern at UF Health Jacksonville. He has held this position since 2021 and is involved in various responsibilities, including hazardous drug risk evaluations and investigational medication dispensing. His role emphasizes compliance with therapeutic policies and research initiatives within the pharmacy department.
Previous Experience at UF Health
Prior to his current role, Christopher Hall worked at UF Health in several capacities. He served as a Pharmacy Intern from 2018 to 2021 and as a Hazardous Sterile Compounding Pharmacy Technician from 2015 to 2018. In these positions, he contributed to projects related to REMS program compliance and sterile compounding master formulation reviews.
Retail Experience at Winn-Dixie
Christopher Hall began his career in retail at Winn-Dixie, where he worked as a Retail Cashier from 2011 to 2013. He later transitioned to a Certified Pharmacy Technician role at the same company from 2013 to 2015 in Jacksonville, Florida. These positions provided him with foundational experience in customer service and pharmacy operations.
Education and Expertise
Christopher Hall studied at the University of Florida, where he earned a Bachelor’s Degree in General Biology from 2015 to 2016. He further pursued a Doctor of Pharmacy (PharmD) degree from 2018 to 2022. Additionally, he obtained a Leadership Professional Certificate in Medical Microbiology and Bacteriology during the same period, enhancing his expertise in the field.
Research and Project Contributions
Throughout his career, Christopher Hall has authored and completed various projects focused on pharmacy compliance and safety. His work includes contributions to REMS program compliance and the development of IVPB to IV push criteria. He has also updated anticoagulation and renal dose adjustment policies, demonstrating his commitment to improving pharmacy practices.